{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:42:42Z","timestamp":1793367762095,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["13FH048KX1 - Evit"],"award-info":[{"award-number":["13FH048KX1 - Evit"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nbt.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:04:52Z","timestamp":1775181892000},"page":"264-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HIV-Gag VLP-based vaccine purification at manufacturing scale: Combination of counterflow centrifugation and nuclease treatment as a key to DNA depletion"],"prefix":"10.1016","volume":"93","author":[{"given":"M.","family":"von Elling-Tammen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Machava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"M\u00f6hle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nunna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bizios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tomala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Krumbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nbt.2026.03.011_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccin"},{"issue":"1","key":"10.1016\/j.nbt.2026.03.011_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles:preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J Nanobiotechnol"},{"issue":"Pt B","key":"10.1016\/j.nbt.2026.03.011_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"N Biotechnol"},{"key":"10.1016\/j.nbt.2026.03.011_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms, advances, and technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front Immunol"},{"issue":"18","key":"10.1016\/j.nbt.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1007\/s00253-019-10038-3","article-title":"Production of HIV-1-based virus-like particles for vaccination: achievements and limits","volume":"103","author":"Cervera","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"10.1016\/j.nbt.2026.03.011_bib6","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1128\/JVI.72.11.9313-9317.1998","article-title":"The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly","volume":"72","author":"Borsetti","year":"1998","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.nbt.2026.03.011_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tim.2012.11.006","article-title":"HIV Gag polyprotein: processing and early viral particle assembly","volume":"21","author":"Bell","year":"2013","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.nbt.2026.03.011_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.nbt.2026.03.011_bib9","unstructured":"FDA, Food and Drug Administration. Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications; 2010."},{"key":"10.1016\/j.nbt.2026.03.011_bib10","article-title":"Optimizing nuclease treatment to enhance anion exchange chromatography of HIV-derived virus-like particles","volume":"1256","author":"Elling-Tammen","year":"2025","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.nbt.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jiec.2020.08.009","article-title":"Cell death in culture: molecular mechanisms, detections, and inhibition strategies","volume":"91","author":"Patil","year":"2020","journal-title":"J Ind Eng Chem"},{"key":"10.1016\/j.nbt.2026.03.011_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1367405","article-title":"The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions","volume":"12","author":"Wolf","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"issue":"11","key":"10.1016\/j.nbt.2026.03.011_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101653","article-title":"Low shear stress increases recombinant protein production and high shear stress increases apoptosis in human cells","volume":"23","author":"Zhan","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.nbt.2026.03.011_bib14","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J Invertebr Pathol"},{"issue":"1","key":"10.1016\/j.nbt.2026.03.011_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000019","article-title":"Advances in lentivirus purification","volume":"16","author":"Moreira","year":"2021","journal-title":"Biotechnol J"},{"issue":"1","key":"10.1016\/j.nbt.2026.03.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biotechadv.2015.11.005","article-title":"Clarification of vaccines: an overview of filter based technology trends and best practices","volume":"34","author":"Besnard","year":"2016","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.nbt.2026.03.011_bib17","series-title":"Continuous Processing in Pharmaceutical Manufacturing","first-page":"385","article-title":"Automated Single-Use Centrifugation Solution for Diverse Biomanufacturing Process","author":"Mehta","year":"2014"},{"issue":"8","key":"10.1016\/j.nbt.2026.03.011_bib18","article-title":"A novel clarification approach for intensified monoclonal antibody processes with 100 million cells\/mL using a single-use fluidized bed centrifuge","volume":"167","author":"Saballus","year":"2021","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.nbt.2026.03.011_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbiotec.2022.05.004","article-title":"Fluidized bed centrifugation of precipitated and flocculated cell cultures: An intensified clarification approach for monoclonal antibodies","volume":"352","author":"Saballus","year":"2022","journal-title":"J Biotechnol"},{"issue":"2","key":"10.1016\/j.nbt.2026.03.011_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/bit.28884","article-title":"Streamlined clarification and capture process for monoclonal antibodies using fluidized bed centrifugation and multi-column chromatography with membrane adsorbers","volume":"122","author":"Schmitz","year":"2025","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nbt.2026.03.011_bib21","article-title":"New technology solutions for lentiviral vector clarification","author":"Dargitz","year":"2022","journal-title":"Cell Cult Dish"},{"key":"10.1016\/j.nbt.2026.03.011_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1106292","article-title":"Boosting productivity for advanced biomanufacturing by re-using viable cells","volume":"11","author":"Reger","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nbt.2026.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1211410","article-title":"A novel hybrid bioprocess strategy addressing key challenges of advanced biomanufacturing","volume":"11","author":"Reger","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nbt.2026.03.011_bib24","unstructured":"Machava M., Elling-Tammen M. von, Kakarla P., Stitz J., Barbe S., Szelwicki M. et al. Virus-Like Particles Purification and Clarification Using Ksep 50 Counterflow Technology 2024."},{"issue":"9","key":"10.1016\/j.nbt.2026.03.011_bib25","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1021\/acs.langmuir.3c03535","article-title":"Investigation of the electrokinetic properties of hiv-based virus-like particles","volume":"40","author":"Wolf","year":"2024","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.nbt.2026.03.011_bib26","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1038\/s41467-019-11182-0","article-title":"The generation and use of recombinant extracellular vesicles as biological reference material","volume":"10","author":"Geeurickx","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nbt.2026.03.011_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2022.01.008","article-title":"Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes","volume":"568","author":"Rosengarten","year":"2022","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.nbt.2026.03.011_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s43393-023-00205-z","article-title":"Strategies and engineering aspects on the scale-up of bioreactors for different bioprocesses","volume":"4","author":"Mello","year":"2024","journal-title":"Syst Microbiol Biomanuf"},{"key":"10.1016\/j.nbt.2026.03.011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461378","article-title":"Capture and purification of human immunodeficiency virus-1 virus-like particles: convective media vs porous beads","volume":"1627","author":"Pereira Aguilar","year":"2020","journal-title":"J Chromatogr A"},{"issue":"47","key":"10.1016\/j.nbt.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1016\/j.vaccine.2019.07.001","article-title":"Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP","volume":"37","author":"Pereira Aguilar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2026.03.011_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chroma.2016.05.053","article-title":"Purification of HIV-1 gag virus-like particles and separation of other extracellular particles","volume":"1455","author":"Steppert","year":"2016","journal-title":"J Chromatogr A"},{"issue":"16","key":"10.1016\/j.nbt.2026.03.011_bib32","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/jssc.201900441","article-title":"At-line multi-angle light scattering detector for faster process development in enveloped virus-like particle purification","volume":"42","author":"Pereira Aguilar","year":"2019","journal-title":"J Sep Sci"},{"key":"10.1016\/j.nbt.2026.03.011_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chroma.2018.12.035","article-title":"Separation of virus-like particles and extracellular vesicles by flow-through and heparin affinity chromatography","volume":"1588","author":"Reiter","year":"2019","journal-title":"J Chromatogr A"},{"issue":"10","key":"10.1016\/j.nbt.2026.03.011_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9101154","article-title":"A four-step purification process for Gag VLPs: from culture supernatant to high-purity lyophilized particles","volume":"9","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.nbt.2026.03.011_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jssc.201600765","article-title":"Separation of HIV-1 gag virus-like particles from vesicular particles impurities by hydroxyl-functionalized monoliths","volume":"40","author":"Steppert","year":"2017","journal-title":"J Sep Sci"},{"key":"10.1016\/j.nbt.2026.03.011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2024.126673","article-title":"Heparin-affinity chromatography is a generic purification platform for chimeric gag VLPs displaying different viral surface antigens","volume":"340","author":"Zollner","year":"2024","journal-title":"Sep Purif Technol"}],"updated-by":[{"DOI":"10.1016\/j.nbt.2026.10.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000}}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:31:22Z","timestamp":1782387082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678426000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"alternative-id":["S1871678426000440"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2026.03.011","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-Gag VLP-based vaccine purification at manufacturing scale: Combination of counterflow centrifugation and nuclease treatment as a key to DNA depletion","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}